WE42899-header-ecpB


Today molecular profiling is the standard method to guide oncologists in the decision on treatment. Recently discovered biomarkers like Tumour Mutation Load and NTRK fusions bring next generation sequencing (NGS) to every pathology laboratory as the technology of choice.

Join us at booth #R16 during the European Congress of Pathology in Nice and discuss with our Scientist and Medical Affair teams as to why in true precision oncology, one size cannot fill all needs and how we can support you to implement the optimal solution based on your needs.

Join our symposium and discuss with thought leaders about the importance of standardisation of new biomarkers and the results of their studies. Share your needs regarding the ideal next generation sequencing workflow and discuss if NGS is now the platform of choice for every pathology laboratory.

Symposium: true precision oncology with next generation sequencing. Can one test fit all needs?

Date Monday 9th September 2019
Time 13:00–14:30
Venue Clio
Chair Albrecht Stenzinger
Institute of Pathology, University Hospital
Heidelberg, Germany

Join Thermo Fisher Scientific Symposium to discuss with thought leaders about:

  • Why one size panel does not fit all needs
  • Why RNA amplicon based panels are a reliable solution for NTRK and other gene fusion biomarker detection
  • The most recent results on Tumour Mutation Burden biomarker standardisation studies and how TCR receptor sequencing may be the new hot biomarker in immuno-oncology

In true precision oncology, one size cannot fill all
needs

Andy Felton
Vice President Product Management,
Thermo Fisher Scientific

Reliable identification of gene fusions by targeted RNA sequencing
 

WE42899-volker

Volker Endris
Institute of Pathology, University Hospital Heidelberg

Next generation sequencing in every pathology laboratory, are we ready?

Dr. Jose Costa
Ipatimup, i3S, Porto

Biomarkers for immuno-oncology: tumour mutational load and beyond. The impact of a multidimensional approach

Dr. Phil Jermann
Institute for Medical Genetics and Pathology,
University Hospital Basel

Visit the below poster sessions to be updated from our scientists on the development of new assays. Join us at Foyer Agora 3 to take the opportunity to discuss why precision medicine needs personalised solutions and how Oncomine solutions provide your reliable results on clinical research samples.

Title Presentation date/Abstract number
Measuring tumour mutational burden from FFPE samples using a PCR-based next-generation sequencing assay
Molecular Pathology Section
E poster
A rapid and customisable NGS library preparation for down to 0.1% allele frequency mutation detection
Molecular Pathology Section
E poster
Application of Oncomine Lung Cell-Free Total Nucleic Acid Research Assay to detect CNV and fusion and SNV in pleural effusions Session: PS-04 | Molecular Pathology
Date: 8 September 2019
Time: 09:30–10:30
Poster number: 023
Elevated TCRB repertoire convergence and clonal expansion in the NSCLC tumour microenvironment of responders to anti-PD-1 monotherapy Session: PS-04 | Molecular Pathology
Date: 8 September 2019
Time: 09:30–10:30
Poster number: 024

If you are unable to attend this poster session the ESP Scientific Committee for ECP event has selected it to part of the Molecular Pathology Best Poster Sessions, times below:

Date: Sunday, 8 September 2019
Time: 16:45–17:15

Characterisation of genetic mutation spectra and identification of gene amplification and fusion variants in cell-free nucleic acid from cultured cancer cell media and liquid biopsy specimens using Oncomine Pan-Cancer Cell-Free Assay Date: 9/10 September 2019
Time: 09:30–10:30
Poster number: 003
Development of an NGS solution for targeted and immune checkpoint therapies Molecular Pathology Section
E poster

Symposium: true precision oncology with next generation sequencing. Can one test fit all needs?

Date Monday 9th September 2019
Time 13:00–14:30
Venue Clio
Chair Albrecht Stenzinger
Institute of Pathology, University Hospital
Heidelberg, Germany

Join Thermo Fisher Scientific Symposium to discuss with thought leaders about:

  • Why one size panel does not fit all needs
  • Why RNA amplicon based panels are a reliable solution for NTRK and other gene fusion biomarker detection
  • The most recent results on Tumour Mutation Burden biomarker standardisation studies and how TCR receptor sequencing may be the new hot biomarker in immuno-oncology

In true precision oncology, one size cannot fill all
needs

Andy Felton
Vice President Product Management,
Thermo Fisher Scientific

Reliable identification of gene fusions by targeted RNA sequencing
 

WE42899-volker

Volker Endris
Institute of Pathology, University Hospital Heidelberg

Next generation sequencing in every pathology laboratory, are we ready?

Dr. Jose Costa
Ipatimup, i3S, Porto

Biomarkers for immuno-oncology: tumour mutational load and beyond. The impact of a multidimensional approach

Dr. Phil Jermann
Institute for Medical Genetics and Pathology,
University Hospital Basel

Visit the below poster sessions to be updated from our scientists on the development of new assays. Join us at Foyer Agora 3 to take the opportunity to discuss why precision medicine needs personalised solutions and how Oncomine solutions provide your reliable results on clinical research samples.

Title Presentation date/Abstract number
Measuring tumour mutational burden from FFPE samples using a PCR-based next-generation sequencing assay
Molecular Pathology Section
E poster
A rapid and customisable NGS library preparation for down to 0.1% allele frequency mutation detection
Molecular Pathology Section
E poster
Application of Oncomine Lung Cell-Free Total Nucleic Acid Research Assay to detect CNV and fusion and SNV in pleural effusions Session: PS-04 | Molecular Pathology
Date: 8 September 2019
Time: 09:30–10:30
Poster number: 023
Elevated TCRB repertoire convergence and clonal expansion in the NSCLC tumour microenvironment of responders to anti-PD-1 monotherapy Session: PS-04 | Molecular Pathology
Date: 8 September 2019
Time: 09:30–10:30
Poster number: 024

If you are unable to attend this poster session the ESP Scientific Committee for ECP event has selected it to part of the Molecular Pathology Best Poster Sessions, times below:

Date: Sunday, 8 September 2019
Time: 16:45–17:15

Characterisation of genetic mutation spectra and identification of gene amplification and fusion variants in cell-free nucleic acid from cultured cancer cell media and liquid biopsy specimens using Oncomine Pan-Cancer Cell-Free Assay Date: 9/10 September 2019
Time: 09:30–10:30
Poster number: 003
Development of an NGS solution for targeted and immune checkpoint therapies Molecular Pathology Section
E poster